Astec Lifesciences
Astec Lifesciences Limited, a prominent player in the agrochemical and pharmaceutical sectors, is headquartered in India. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of active ingredients and intermediates. With a strong presence in both domestic and international markets, Astec Lifesciences focuses on crop protection, specialty chemicals, and custom synthesis. The company is renowned for its commitment to quality and innovation, offering unique products that cater to the evolving needs of the agricultural and pharmaceutical industries. Notable achievements include a robust portfolio of patented formulations and a reputation for excellence in regulatory compliance. As a key contributor to sustainable agriculture, Astec Lifesciences continues to strengthen its market position through strategic partnerships and a dedication to research and development.
DitchCarbon Score
How does Astec Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astec Lifesciences's score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Astec Lifesciences's reported carbon emissions
In 2023, Astec Lifesciences reported total carbon emissions of approximately 19,072,000 kg CO2e for Scope 1 and about 45,092,000 kg CO2e for Scope 3. This marked a notable increase from 2022, where Scope 1 emissions were around 23,309,000 kg CO2e and Scope 3 emissions reached approximately 74,046,000 kg CO2e. For 2024, while specific emissions data is not disclosed, the company reported a Scope 1 and 2 emission intensity of about 4,970 kg CO2e per tonne of revenue. Astec Lifesciences has not set specific reduction targets or climate pledges, indicating a potential area for future commitment. The absence of disclosed Scope 2 emissions suggests a need for further transparency in their overall carbon footprint. As the company continues to operate within the pharmaceutical sector, addressing these emissions will be crucial for aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 23,309,000 | 00,000,000 |
| Scope 2 | - | - |
| Scope 3 | 74,046,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Astec Lifesciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
